Glory Health Industry (HKSE:02329) Notes Receivable: HK$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Glory Health Industry Notes Receivable?

Glory Health Industry HKSE:02329 +3.37% Notes Receivable is HK$0 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Glory Health Industry's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0 Mil.

Glory Health Industry Notes Receivable Related Terms

Glory Health Industry Notes Receivable Historical Data

* Premium members only.

The historical data trend for Glory Health Industry's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glory Health Industry Notes Receivable Chart

Glory Health Industry Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Glory Health Industry Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Glory Health Industry Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0 Mil mean?
Glory Health Industry (HKSE:02329) has a Notes Receivable of HK$0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Glory Health Industry and its competitors.
Is Glory Health Industry's Notes Receivable too high?
Glory Health Industry's current Notes Receivable is HK$0 Mil.
How does Glory Health Industry's Notes Receivable compare to competitors?
Glory Health Industry's Notes Receivable of HK$0 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Real Estate company?
A good Notes Receivable depends on the Real Estate industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Glory Health Industry and its competitors. Glory Health Industry's current Notes Receivable is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glory Health Industry stock overvalued right now?
Based on GuruFocus' analysis, Glory Health Industry (HKSE:02329) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.09 — trading 130% above its estimated fair value. The current Notes Receivable is HK$0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Glory Health Industry (HKSE:02329), the current Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Glory Health Industry Business Description

Address Chongwenmenwai Street, Building 1, East Block, Hademen Plaza, No. 8 Courtyard, Dongcheng District, Beijing, CHN, 100062
Glory Health Industry Ltd is an investment holding company. The company's operating segments are Property development that develops and sells commercial and residential properties; primary land construction and development services that derive revenue from primary land development, including services for resettlement, construction of land infrastructure, and ancillary public facilities on land owned by the local governments; Property investment that derives rental income from investment properties developed by the group; and Property management that derive income from property management and related services. The majority of the revenue is derived from the Property development segment. All the company's revenue is derived from the PRC.